UCB Wins Two Key US Approvals: Bimzelx In Psoriasis, Zilbrysq In gMG

Launches To Follow In A Month, Late 2023

Night speedy motion blur international race track with starting finishing line and confetti
Bimzelx crossed the US finish line after a lengthy delay • Source: Shutterstock

More from New Products

More from Scrip